⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4882477 | 0.97 | — | — | |
| Sulfuric Acid SCHEMBL11213693 | 0.88 | BLM (0.36) | — | |
| SCHEMBL11860691 | 0.74 | — | — | |
| SCHEMBL6984530 | 0.73 | — | — | |
| Methyl Carbamate SCHEMBL788713 | 0.72 | ALDH1A1 (0.50) | — | |
| Methyl Carbamate SCHEMBL4140 | 0.72 | — | — | |
| SCHEMBL158332 | 0.71 | — | — | |
| SCHEMBL6231532 | 0.71 | — | — | |
| Methoxymethane SCHEMBL15238818 | 0.71 | CRBN (0.56) | — | |
| SCHEMBL9105 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 473 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119859152-A | Rayleigh Lu Geli and three-step synthesis method thereof | 诚达药业股份有限公司 | 2025-04-22 | — | — | CN | claimed |
| CN-119859135-A | Rayleigh Lu Geli intermediate and preparation method thereof | 浙江工业大学 | 2025-04-22 | — | — | CN | claimed |
| US-20230265083-A1 | Heterocycle CDK Inhibitors And Their Use Thereof | PRELUDE THERAPEUTICS INCORPORATED | 2023-08-24 | — | — | US | claimed |
| US-20230242543-A1 | CDK Inhibitors And Their Use As Pharmaceuticals | PRELUDE THERAPEUTICS INCORPORATED | 2023-08-03 | — | — | US | claimed |
| US-20230144528-A1 | CDK Inhibitors And Their Use As Pharmaceuticals | PRELUDE THERAPEUTICS, INCORPORATED | 2023-05-11 | — | — | US | claimed |
| WO-2023056441-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | PRELUDE THERAPEUTICS INCORPORATED (US) | 2023-04-06 | — | — | WO | claimed |
| CN-113999145-B | Synthetic method of nafamostat mesylate | 开封明仁药业有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-114786673-A | CDK inhibitors and their use as medicaments | 普莱鲁德疗法有限公司 | 2022-07-22 | — | — | CN | claimed |
| EP-4028005-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | Prelude Therapeutics, Incorporated (US) | 2022-07-20 | — | — | EP | claimed |
| WO-2022035799-A1 | HETEROCYCLE CDK INHIBITORS AND THEIR USE THEREOF | PRELUDE THERAPEUTICS INCORPORATED (US) | 2022-02-17 | — | — | WO | claimed |
| US-20090047250-A1 | Methods for treating or preventing neuroinflammation or autoimmune diseases | ELFORD HOWARD L | 2009-02-19 | — | — | US | claimed |
| CN-101292069-A | Reducing the water and water vapour absorbence and enhancing the dimensional stability of paper and paper products and use of coated paper products | BASF SE (DE) | 2008-10-22 | — | — | CN | claimed |
| CN-101245037-A | Preparation method of oxymethylisourea acetate | JUHUA GROUP CORP (CN) | 2008-08-20 | — | — | CN | claimed |
| CN-101124199-A | 5-substituted-2-phenylamino-benzamides as MEK inhibiting substances | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2008-02-13 | — | — | CN | claimed |
| CN-1703307-A | Method for improving the surface hardness of a wooden body using an aqueous solution of an impregnating agent | BASF AG (DE) | 2005-11-30 | — | — | CN | claimed |
| CN-1703308-A | Method for improving the durability, dimensional stability and surface hardness of a wooden body | BASF AG (DE) | 2005-11-30 | — | — | CN | claimed |
| US-6410166-B1 | Organic electroluminescence device doping device and organic electroluminescence device | FUTABA CORPORATION (JP) | 2002-06-25 | — | — | US | claimed |
| US-5610233-A | AMINO RESIN CURING RESIN, ACID CATALYST | EASTMAN CHEMICAL COMPANY (US) | 1997-03-11 | — | — | US | claimed |
| WO-1994020580-A1 | THERMOSETTING COATING COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 1994-09-15 | — | — | WO | claimed |
| US-5288820-A | Comprising acetoacetate-modified polyester or acrylic polymer, amino resin crosslinker, sulfonic acid curing agent and limonene epoxides as coloration inhibitors | EASTMAN KODAK COMPANY (US) | 1994-02-22 | — | — | US | claimed |